{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:41:58Z","timestamp":1791409318446,"version":"4.3.3"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100009243","name":"Direction G\u00e9n\u00e9rale de l'offre de Soins","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Unraveling the molecular mechanisms that regulate the biology of metastasis-competent circulating tumor cells (CTCs) is urgently needed to understand metastasis formation and tumor relapse. Our group previously established the first cell line (CTC-MCC-41) derived from metastasis-competent CTCs of a patient with colon cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>In this study, we analyzed the transcriptome of CTC-MCC-41 cells using Human Genome U133 Plus 2.0 microarrays with the aim of unraveling the molecular basis of their special features (stem cell properties and ability to initiate and support metastasis formation).<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Comparison of the transcriptome data of metastasis-competent CTC-MCC-41 cells and of HT-29 cells (derived from a primary colon cancer) highlights the differential expression of genes that regulate energy metabolism [peroxisome proliferator-activated receptor \u03b3 coactivator 1A (PPARGC1A), peroxisome proliferator-activated receptor \u03b3 coactivator 1B (PPARGC1B), fatty acid binding protein 1 (FABP1), aldehyde dehydrogenase 3 family member A1 (ALDH3A1)], DNA repair [BRCA1 interacting protein C-terminal helicase 1 (BRIP1), Fanconi anemia complementation group B (FANCB), Fanconi anemia complementation group M (FANCM)], and stemness [glutaminase 2 (GLS2), cystathionine-beta-synthase (CBS), and cystathionine gamma-lyase (CTH)]. The differential expression of 20 genes was validated by quantitative reverse transcription PCR.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>This study gives a comprehensive outlook on the molecular events involved in colon cancer progression and provides potential CTC biomarkers that may help develop new therapies to specifically target CTCs with stem cell properties that cause metastases and tumor relapse in patients with colon cancer.<\/jats:p><\/jats:sec>","DOI":"10.1373\/clinchem.2016.263582","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T02:57:27Z","timestamp":1482461847000},"page":"700-713","source":"Crossref","is-referenced-by-count":71,"title":["Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair"],"prefix":"10.1093","volume":"63","author":[{"given":"Catherine","family":"Alix-Panabi\u00e8res","sequence":"first","affiliation":[{"name":"Laboratory of Rare Human Circulating Cells, Department of Cellular and Tissue Biopathology of Tumors, University Medical Centre, Montpellier, France"},{"name":"EA2415 \u2013 Help for Personalized Decision: Methodological Aspects, University Institute of Clinical Research (IURC), University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Cayrefourcq","sequence":"first","affiliation":[{"name":"Laboratory of Rare Human Circulating Cells, Department of Cellular and Tissue Biopathology of Tumors, University Medical Centre, Montpellier, France"},{"name":"EA2415 \u2013 Help for Personalized Decision: Methodological Aspects, University Institute of Clinical Research (IURC), University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Mazard","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Institut du Cancer \u00e0 Montpellier (ICM), France"},{"name":"Institut du Cancer \u00e0 Montpellier (ICM), Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Maudelonde","sequence":"first","affiliation":[{"name":"Laboratory of Hormonal and Cell Biology, University Medical Centre, Montpellier, France"},{"name":"EA2415 \u2013 Help for Personalized Decision: Methodological Aspects, University Institute of Clinical Research (IURC), University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Assenat","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, University Medical Centre, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Assou","sequence":"first","affiliation":[{"name":"University of Montpellier, UFR de M\u00e9decine, Montpellier, France"},{"name":"INSERM U1183; Institute for Regenerative Medicine and Biotherapy, CHU Montpellier, H\u00f4pital Saint-Eloi, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"key":"2020022606130670800_B1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.molmed.2010.07.001","article-title":"Circulating tumour cells in cancer patients: challenges and perspectives","volume":"16","author":"Pantel","year":"2010","journal-title":"Trends Mol Med"},{"key":"2020022606130670800_B2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrc3820","article-title":"Challenges in circulating tumour cell research","volume":"14","author":"Alix-Panabieres","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2020022606130670800_B3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1158\/2159-8290.CD-15-1483","article-title":"Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy","volume":"6","author":"Alix-Panabieres","year":"2016","journal-title":"Cancer Discov"},{"key":"2020022606130670800_B4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1373\/clinchem.2015.242537","article-title":"Functional studies on viable circulating tumor cells","volume":"62","author":"Pantel","year":"2016","journal-title":"Clin Chem"},{"key":"2020022606130670800_B5","doi-asserted-by":"crossref","first-page":"815","DOI":"10.18632\/oncoscience.195","article-title":"Cell lines from circulating tumor cells","volume":"2","author":"Pantel","year":"2015","journal-title":"Oncoscience"},{"key":"2020022606130670800_B6","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1158\/0008-5472.CAN-14-2613","article-title":"Establishment and characterization of a cell line from human circulating colon cancer cells","volume":"75","author":"Cayrefourcq","year":"2015","journal-title":"Cancer Res"},{"key":"2020022606130670800_B7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jnci\/59.1.221","article-title":"One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice","volume":"59","author":"Fogh","year":"1977","journal-title":"J Natl Cancer Inst"},{"key":"2020022606130670800_B8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng1201-365","article-title":"Minimum information about a microarray experiment (MIAME)-toward standards for microarray data","volume":"29","author":"Brazma","year":"2001","journal-title":"Nat Genet"},{"key":"2020022606130670800_B9","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns","volume":"95","author":"Eisen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020022606130670800_B10","doi-asserted-by":"crossref","first-page":"16942","DOI":"10.1074\/jbc.M412757200","article-title":"Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha\/Nur77","volume":"280","author":"Lee","year":"2005","journal-title":"J Biol Chem"},{"key":"2020022606130670800_B11","doi-asserted-by":"crossref","first-page":"39174","DOI":"10.1074\/jbc.M908888199","article-title":"Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells","volume":"275","author":"Butt","year":"2000","journal-title":"J Biol Chem"},{"key":"2020022606130670800_B12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1074\/mcp.M600477-MCP200","article-title":"Proteomics demonstration that normal breast epithelial cells can induce apoptosis of breast cancer cells through insulin-like growth factor-binding protein-3 and maspin","volume":"6","author":"Toillon","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"2020022606130670800_B13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1634\/stemcells.2006-0352","article-title":"A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas","volume":"25","author":"Assou","year":"2007","journal-title":"Stem Cells"},{"key":"2020022606130670800_B14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.mrfmmm.2005.03.007","article-title":"Human DNA repair genes, 2005","volume":"577","author":"Wood","year":"2005","journal-title":"Mutat Res"},{"key":"2020022606130670800_B15","doi-asserted-by":"crossref","first-page":"e1002018","DOI":"10.1371\/journal.pcbi.1002018","article-title":"Genome-scale metabolic modeling elucidates the role of proliferative adaptation in causing the Warburg effect","volume":"7","author":"Shlomi","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"2020022606130670800_B16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.gde.2008.02.003","article-title":"Brick by brick: metabolism and tumor cell growth","volume":"18","author":"Deberardinis","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"2020022606130670800_B17","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1158\/0008-5472.CAN-11-1011","article-title":"PGC1alpha promotes tumor growth by inducing gene expression programs supporting lipogenesis","volume":"71","author":"Bhalla","year":"2011","journal-title":"Cancer Res"},{"key":"2020022606130670800_B18","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1158\/1078-0432.CCR-14-2290","article-title":"SIRT1\/PGC1alpha-dependent increase in oxidative phosphorylation supports chemotherapy resistance of colon cancer","volume":"21","author":"Vellinga","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2020022606130670800_B19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"2020022606130670800_B20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"2020022606130670800_B21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.molcel.2011.08.044","article-title":"PGC-1alpha, a key modulator of p53, promotes cell survival upon metabolic stress","volume":"44","author":"Sen","year":"2011","journal-title":"Mol Cell"},{"key":"2020022606130670800_B22","doi-asserted-by":"crossref","first-page":"E116","DOI":"10.1152\/ajpendo.00119.2015","article-title":"p53 regulates expression of uncoupling protein 1 through binding and repression of PPARgamma coactivator-1alpha","volume":"310","author":"Hallenborg","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020022606130670800_B23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s004280050034","article-title":"Protein expression of p53, p21 (WAF1\/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas","volume":"436","author":"Bukholm","year":"2000","journal-title":"Virchows Arch"},{"key":"2020022606130670800_B24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mrfmmm.2006.01.007","article-title":"Comparison of growth inhibition profiles and mechanisms of apoptosis induction in human colon cancer cell lines by isothiocyanates and indoles from Brassicaceae","volume":"599","author":"Pappa","year":"2006","journal-title":"Mutat Res"},{"key":"2020022606130670800_B25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jamcollsurg.2003.08.008","article-title":"Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer","volume":"198","author":"Linjawi","year":"2004","journal-title":"J Am Coll Surg"},{"key":"2020022606130670800_B26","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1128\/MCB.16.10.5857","article-title":"Induction of apoptosis by human Nbk\/Bik, a BH3-containing protein that interacts with E1B 19K","volume":"16","author":"Han","year":"1996","journal-title":"Mol Cell Biol"},{"key":"2020022606130670800_B27","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1038\/sj.onc.1209665","article-title":"Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells","volume":"25","author":"Rodrigues","year":"2006","journal-title":"Oncogene"},{"key":"2020022606130670800_B28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/mutage\/ger075","article-title":"The role of ABC transporters in progression and clinical outcome of colorectal cancer","volume":"27","author":"Hlavata","year":"2012","journal-title":"Mutagenesis"},{"key":"2020022606130670800_B29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2789","article-title":"ABC transporters in cancer: more than just drug efflux pumps","volume":"10","author":"Fletcher","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2020022606130670800_B30","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1248\/bpb.30.1144","article-title":"Correlation of induction of ATP binding cassette transporter A5 (ABCA5) and ABCB1 mRNAs with differentiation state of human colon tumor","volume":"30","author":"Ohtsuki","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"2020022606130670800_B31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1389200043489199","article-title":"The MRP-related and BCRP\/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation","volume":"5","author":"Haimeur","year":"2004","journal-title":"Curr Drug Metab"},{"key":"2020022606130670800_B32","first-page":"2401","article-title":"Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas","volume":"6","author":"Hinoshita","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2020022606130670800_B33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2741\/e767","article-title":"BRIP1, a potential candidate gene in development of non-BRCA1\/2 breast cancer","volume":"8","author":"Ouhtit","year":"2016","journal-title":"Front Biosci (Elite Ed)"},{"key":"2020022606130670800_B34","doi-asserted-by":"crossref","first-page":"11315","DOI":"10.1128\/JVI.01533-14","article-title":"High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells","volume":"88","author":"Chlon","year":"2014","journal-title":"J Virol"},{"key":"2020022606130670800_B35","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1182\/blood-2012-02-408674","article-title":"Overcoming reprogramming resistance of Fanconi anemia cells","volume":"119","author":"Muller","year":"2012","journal-title":"Blood"},{"key":"2020022606130670800_B36","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1038\/ncomms5330","article-title":"Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"key":"2020022606130670800_B37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.stemcr.2015.12.001","article-title":"Overcoming Pluripotent Stem Cell Dependence on the Repair of Endogenous DNA Damage","volume":"6","author":"Chlon","year":"2016","journal-title":"Stem Cell Reports"},{"key":"2020022606130670800_B38","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1073\/pnas.1001006107","article-title":"Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function","volume":"107","author":"Hu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020022606130670800_B39","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1073\/pnas.1002459107","article-title":"Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species","volume":"107","author":"Suzuki","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020022606130670800_B40","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4161\/cc.24478","article-title":"p63 regulates glutaminase 2 expression","volume":"12","author":"Giacobbe","year":"2013","journal-title":"Cell Cycle"},{"key":"2020022606130670800_B41","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd2425","article-title":"Hydrogen sulphide and its therapeutic potential","volume":"6","author":"Szabo","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"2020022606130670800_B42","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1073\/pnas.1306241110","article-title":"Tumor-derived hydrogen sulfide, produced by cystathionine-beta-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer","volume":"110","author":"Szabo","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020022606130670800_B43","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.cellsig.2014.08.023","article-title":"Wnt\/beta-catenin signaling induces the transcription of cystathionine-gamma-lyase, a stimulator of tumor in colon cancer","volume":"26","author":"Fan","year":"2014","journal-title":"Cell Signal"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/63\/3\/700\/32646714\/clinchem0700.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/63\/3\/700\/32646714\/clinchem0700.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T05:23:14Z","timestamp":1601270594000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/63\/3\/700\/5612910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,1]]},"published-print":{"date-parts":[[2017,3,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2016.263582","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,3,1]]},"published":{"date-parts":[[2017,3,1]]}}}